经皮脾静脉途径联合TIPS治疗伴海绵样变性的门静脉血栓

目的 探讨经皮脾静脉途径联合TIPS治疗伴海绵样变性的门静脉血栓的可行性、安全性和疗效.方法 对3例门静脉血栓伴门脉海绵样变性患者行经皮脾穿脾静脉途径开通门静脉,联合TIPS重建门静脉分流道.随访22～40个月,观察治疗效果、支架通畅情况、肝功能变化和并发症.结果 3例均成功.其中1例支架经由显著扩张的海绵样变性的侧支放置,术后7个月内出现2次肝性脑病前期症状,药物治疗后症状消失.1例患者于术后6个月内出现持续性的胆红素增高,最高总胆红素为88.2μmoL/L,直接胆红素68.7 μmoL/L.予以保肝、降黄治疗后总胆红素维持在(44.4±11.6)μmol/L,直接胆红素(29.7±12.8)μmol/L.较术前无显著变化.第3例术后恢复良好.3例无术中并发症,术后随访22～40个月,支架血流通畅,未再发静脉曲张出血.结论 在有限的治疗伴有海绵样变性的门静脉血栓的方法选择中,经皮脾穿刺脾静脉途径开通门静脉,联合TIPS是安全可行和有效的,虽然技术要求上更困难和更具挑战性.

Percutaneous transsplenic portal catheterization combined with TIPS for the treatment of portal vein thrombosis associated with cavernous transformation

Objective To evaluate the feasibility, safety and efficacy of percutaneous transsplenic portal catheterization combined with transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal vein thrombosis (PVT) associated with cavernous transformation. Methods Percutaneous transsplenic portal catheterization was performed in 3 patients suffered from PVT with cavernous transformation in order to reopen the portal vein, then, TIPS was carried out to establish the portal shunt. A follow-up of 2...